Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-<i>N</i>-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors.

RSC Adv · 2026 · PMC13339992 · PMID 42416732

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This range demonstrates that our most potent compound (8m) was 25 000 times more potent than acarbose, which is a highly significant effect.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-&lt;i&gt;N&lt;/i&gt;-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors.

The sentences

Novel 4-formyl-1,3-phenylene-bisoxy-bis(methylene)-bis(1,2,3-triazole-<i>N</i>-phenylacetamide) derivatives as a new category of excellent α-glucosidase inhibitors.